Maximizing HIV Prevention: Building the Case for Social and Economic Vaccines

The XVII International AIDS Conference in Mexico City sheds a global spotlight on both the progress in combating HIV and AIDS and the failure of our current prevention efforts to stem the epidemic. Despite increased funding for and access to HIV and AIDS treatment around the world, the imperative to vastly increase HIV prevention remains urgent: for every two people put on treatment, five more are newly infected.1 In the absence of a medical vaccine, the course of the epidemic will depend on how the global community rises to the challenge of prevention.